Showing 1 - 8 results of 8 for search 'Dagmar Alber', query time: 0.03s Refine Results
  1. 1
    'If I am on ART, my new-born baby should be put on treatment immediately': Exploring the acceptability, and appropriateness of Cepheid Xpert HIV-1 Qual assay for early infant diagnosis of HIV in Malawi.

    'If I am on ART, my new-born baby should be put on treatment immediately': Exploring the acceptability, and appropriateness of Cepheid Xpert HIV-1 Qual assay for early infant diagn... by Maggie Nyirenda-Nyang'wa, Moses Kelly Kumwenda, Shona Horter, Mina C Hosseinipour, Maganizo Chagomerana, Neil Kennedy, Derek Fairley, Kevin Mortimer, Victor Mwapasa, Chisomo Msefula, Nigel Klein, Dagmar Alber, Angela Obasi

    Published 2023-01-01
    Get full text
    Article
  2. 2
    ‘If I am on ART, my new-born baby should be put on treatment immediately’: Exploring the acceptability, and appropriateness of Cepheid Xpert HIV-1 Qual assay for early infant diagnosis of HIV in Malawi

    ‘If I am on ART, my new-born baby should be put on treatment immediately’: Exploring the acceptability, and appropriateness of Cepheid Xpert HIV-1 Qual assay for early infant diagn... by Maggie Nyirenda-Nyang’wa, Moses Kelly Kumwenda, Shona Horter, Mina C. Hosseinipour, Maganizo Chagomerana, Neil Kennedy, Derek Fairley, Kevin Mortimer, Victor Mwapasa, Chisomo Msefula, Nigel Klein, Dagmar Alber, Angela Obasi

    Published 2023-01-01
    Get full text
    Article
  3. 3
    Costing and cost-effectiveness of Cepheid Xpert HIV -1 Qual Assay using whole blood protocol versus PCR by Abbott Systems in Malawi

    Costing and cost-effectiveness of Cepheid Xpert HIV -1 Qual Assay using whole blood protocol versus PCR by Abbott Systems in Malawi by Maggie Nyirenda-Nyang'wa, Gerald Manthalu, Matthias Arnold, Dominic Nkhoma, Mina C. Hosseinipour, Maganizo Chagomerana, Precious Chibwe, Kevin Mortimer, Neil Kennedy, Derek Fairley, Victor Mwapasa, Chisomo Msefula, Henry C. Mwandumba, Jobiba Chinkhumba, Nigel Klein, Dagmar Alber, Angela Obasi

    Published 2022-08-01
    Get full text
    Article
  4. 4
    FcMBL magnetic bead-based MALDI-TOF MS rapidly identifies paediatric blood stream infections from positive blood cultures

    FcMBL magnetic bead-based MALDI-TOF MS rapidly identifies paediatric blood stream infections from positive blood cultures by Kerry Anne Kite, Sahil Loomba, Thomas J. Elliott, Francis Yongblah, Shanda L. Lightbown, Thomas J. Doyle, Lily Gates, Dagmar Alber, George A. Downey, Michael T. McCurdy, James A. Hill, Michael Super, Donald E. Ingber, Nigel Klein, Elaine Cloutman-Green

    Published 2022-01-01
    Get full text
    Article
  5. 5
    FcMBL magnetic bead-based MALDI-TOF MS rapidly identifies paediatric blood stream infections from positive blood cultures.

    FcMBL magnetic bead-based MALDI-TOF MS rapidly identifies paediatric blood stream infections from positive blood cultures. by Kerry Anne Kite, Sahil Loomba, Thomas J Elliott, Francis Yongblah, Shanda L Lightbown, Thomas J Doyle, Lily Gates, Dagmar Alber, George A Downey, Michael T McCurdy, James A Hill, Michael Super, Donald E Ingber, Nigel Klein, Elaine Cloutman-Green

    Published 2022-01-01
    Get full text
    Article
  6. 6
    SARS-CoV-2 infection and antibody seroprevalence in routine surveillance patients, healthcare workers and general population in Kita region, Mali: an observational study 2020–2021

    SARS-CoV-2 infection and antibody seroprevalence in routine surveillance patients, healthcare workers and general population in Kita region, Mali: an observational study 2020–2021... by Ulla Ashorn, Per Ashorn, Nigel Klein, Samba O Sow, Camilla Ducker, Elaine Cloutman-Green, Dagmar Alber, Fadima Cheick Haidara, Juho Luoma, Laura Adubra, Henry Badji, Fatoumata Diallo, Rikhard Ihamuotila, Owen Martell, Uma U Onwuchekwa, Oumar Samaké, Awa Traore, Kevin Wilson, Yue-Mei Fan

    Published 2022-06-01
    Get full text
    Article
  7. 7
    Statistical analysis plan for the LAKANA trial: a cluster-randomized, placebo-controlled, double-blinded, parallel group, three-arm clinical trial testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11-month-old infants in Mali

    Statistical analysis plan for the LAKANA trial: a cluster-randomized, placebo-controlled, double-blinded, parallel group, three-arm clinical trial testing the effects of mass drug... by Juho Luoma, Laura Adubra, Dagmar Alber, Per Ashorn, Ulla Ashorn, Elaine Cloutman-Green, Fatoumata Diallo, Camilla Ducker, Riku Elovainio, Yue-Mei Fan, Lily Gates, Gwydion Gruffudd, Tiia Haapaniemi, Fadima Haidara, Lotta Hallamaa, Rikhard Ihamuotila, Nigel Klein, Owen Martell, Samba Sow, Taru Vehmasto, Yin Bun Cheung

    Published 2023-11-01
    Get full text
    Article
  8. 8
    Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial

    Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomiz... by Laura Adubra, Dagmar Alber, Per Ashorn, Ulla Ashorn, Yin Bun Cheung, Elaine Cloutman-Green, Fatoumata Diallo, Camilla Ducker, Riku Elovainio, Yue-Mei Fan, Lily Gates, Gwydion Gruffudd, Tiia Haapaniemi, Fadima Haidara, Lotta Hallamaa, Rikhard Ihamuotila, Nigel Klein, Juho Luoma, Owen Martell, Samba Sow, Taru Vehmasto, LAKANA Trial Team

    Published 2023-01-01
    Get full text
    Article

Search Tools: